Navigating a Pathway to Improve Treatment of Psoriasis

Navigating a Pathway to Improve Treatment of Psoriasis is organized by Annenberg Center for Health Sciences At Eisenhower.

Opens: Sep 30, 2019
Expires: Sep 30, 2020

Target Audience:
The target learning audience is a national audience of dermatologists, dermatology physician assistants, nurse practitioners, and other clinicians who treat patients with moderate-to-severe psoriasis.

Available Credit: 1.00 AMA PRA Category 1 Credit™.

Content Areas:
• Comorbidities in patients with psoriasis
• Biologic treatments for psoriasis
• Safety of biologic treatments for psoriasis
• TNF-α inhibitors
• IL-17 inhibitors
• IL-23 inhibitors

Learning Objectives:
At the conclusion of this activity, participants should be better able to:
• Describe the most common adverse events associated with biologic treatments for psoriasis
• Select biologic treatments based on patient characteristics and comorbid conditions
• Apply the results of clinical trials, expert recommendations, and consensus guidelines to develop treatment plans

Additional details will be posted as soon as information is available.